Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines

Heterologous “prime-boost” regimens that involve priming with plasmid DNA vaccines and boosting with recombinant viral vectors have been shown to elicit potent virus-specific cytotoxic T-lymphocyte responses. Increasing evidence, however, suggests that the utility of recombinant viral vectors in hum...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Barouch, Dan H., McKay, Paul F., Sumida, Shawn M., Santra, Sampa, Jackson, Shawn S., Gorgone, Darci A., Lifton, Michelle A., Chakrabarti, Bimal K., Xu, Ling, Nabel, Gary J., Letvin, Norman L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2003
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC167238/
https://ncbi.nlm.nih.gov/pubmed/12885892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.77.16.8729-8735.2003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires